The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe - A review of published results

Central European Journal of Public Health

Volumn 16, Issue 3, 2008, Pages 99-105

  Podlekareva, Daria ^a,e   Bannister, Wendy ^b   Mocroft, Amanda ^b   Abrosimova, Ludmila ^c   Karpov, Igor ^d   Lundgren, Jens D ^a   Kirk, Ole ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Botkin Hospital of Infectious Diseases   (Russian Federation)

^d BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Collaboration; Eastern Europe; EuroSIDA study; HIV infection management

Indexed keywords

EID: 53749085825     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3490     Document Type: Review

References (17)

1. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet. 2003 Mar 22;361(9362):1035-44.
2. Oancea C, Mollerup D, Nielsen M, Kirk O, editors. EuroSIDA: a multicentre study. Tracking HIV/AIDS across Europe 2003. Hvidovre: Copenhagen HIV Programme; 2008.
3. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Mon forte A, et al; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003 Jul 5;362(9377):22-9.
4. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19.
5. Podlekareva D, Bannister W, Viksna L, Mocroft A, Knysz B, Reiss P, et al. HIV-patients across Europe: regional differences in patient characteristics. In: Seventh International Congress on Drug Therapy in HIV Infection; 2004 Nov 14-18; Glasgow. Glasgow: Clinical Care Options; 2004. p. 33-4. Abstract P-67.
6. Podlekareva D, Bannister W, Viksna L, Mocroft A, Knysz B, Reiss P, et al. HIV-patients across Europe: regional differences in patient characteristics and AIDS diagnoses. In: 15th European Congress of Clinical Microbiology and Infectious Diseases; 2005 Apr 2-5; Copenhagen. Copenhagen: ECCMID; 2005. p. 52-3. Abstract O-217.
7. Blaxhult A, Fox Z, Colebunders R, Francioli P, Ben-Ishai Z, Fätkenheuer G, et al; EuroSIDA Study Group. Regional and temporal changes in AIDS in Europe before HAART. Epidemiol Infect. 2002 Dec;129(3):565-76.
8. Mocroft A, Youle M, Phillips AN, Halai R, Easterbrook P, Johnson MA, et al; Royal Free/Chelsea and Westminster Hospitals Collaborative Group. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Arch Intern Med. 1998 Mar 9;158(5):491-7.
9. Bannister WP, Kirk O, Gatell JM, Knysz B, Viard JP, Mens H, et al; EuroSIDA Study Group. Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe. J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37.
10. Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, Kjaer J, et al; EuroSIDA Study Group. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Ther. 2006; 11(6):707-15.
11. Mocroft A, Horban A, Clotet B, d'Arminio Monforte A, Bogner JR, Aldins P, et al; EuroSIDA Study Group. Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999. HIV Med. 2008 Jan; 9(1):41-6.
12. Podlekareva D, Reekie J, Rakhmanova A, Horban A, Mocroft A, Karpov I, et al. Indicators of the use of health care interventions across Europe. In: 15th Conference on Retroviruses and Opportunistic Infections; 2008 Feb 3-6; Boston. Boston: CROI; 2008. Abstract O-138.
13. Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European Region. HIV Med. 2008 Apr 10.
14. Lazarus JV, Bollerup A, Matic S. HIV/AIDS in eastern Europe: more than a sexual health crisis. Cent Eur J Public Health. 2006 Jun;14(2):55-8.
15. World Health Organisation. Anti-tuberculosis drug resistance in the world. Report No. 4. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva: WHO; 2008.
16. Podlekareva D, Mocroft A, Panteleev A, Toibaro J, Rakhmanova A, Riekstina V, et al. Characteristics and clinical outcome of patients with HIV-associated tuberculosis (HIV/TB) in Europe and Argentina. In: 15th Conference on Retroviruses and Opportunistic Infections; 2008 Feb 3-6; Boston. Boston: CROI; 2008. Abstract K-181.
17. Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. Int J Drug Policy. 2007 Aug;18(4):271-80.